Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference27 articles.
1. Mechanism of action of Imeglimin: a novel therapeutic agent for type 2 diabetes;Hallakou-Bozec;Diabetes Obes Metab,2021
2. Imeglimin preserves islet β-cell mass in Type 2 diabetic ZDF rats;Hallakou-Bozec;Endocrinol, Diabetes Metabol,2020
3. Imeglimin: a potential new multi-target drug for Type 2 diabetes;Vuylsteke;Drugs R D,2015
4. Imeglimin: a new promising and effective weapon in the treatment of Type 2 Diabetes;Doupis;TouchREVIEWS Endocrinol,2021
5. Glucose-lowering effects of Imeglimin and its possible beneficial effects on Diabetic Complications;Yanai;Biology (Basel),2023